Medical Professionals

We are here to guide you to the most recent research and resources to better support your patients.

Caring for Melo Patients

Melorheostosis is a rare, non-hereditary sclerosing bone dysplasia characterized by cortical hyperostosis. Given its rarity, and variable presentations and complications, clinicians play a critical role in early recognition, appropriate management, and coordination of often multidisciplinary care. This page provides a concise overview to support providers caring for those with melorheostosis.

Resources for Doctors & Researchers

Worldwide Map of Melorheostosis Patients

See the breadth of the melorheostosis community worldwide.

Read Patient Experiences with Melorheostosis

Hundreds of patients’ experiences told in their own words: how and when diagnosed, where and how affected, surgeries, pain management, and attempts at treatments, etc

Resources for Adult and Pediatric Patients

Resources to help patients better understand melorheostosis, manage their health, participate in research, and connect with a supportive community.

National Institutes of Health (NIH) Melorheostosis Publications

Publications from the historic and ongoing natural history study which identified MAP2K1 and SMAD3 genes and helped transform the melorheostosis landscape.

Other Key Melorheostosis Publications

Read on for key melorheostosis publications building on decades of research.

Melorheostosis Association International Conferences

Gatherings of patients and their families, experienced doctors, and researchers. Videos and more from conferences dating back to 2003.

Research

Learn more about recent research into the causative genes identified for various forms of melorheostosis, along with case studies on patient experience and symptom management.

Ongoing Patient Studies

The National Institutes of Health has an ongoing natural history and pathogenesis study designed to better understand the causes, progression, and biological mechanisms of the disease. Participants undergo detailed clinical evaluations and are followed over time. We encourage all adult patients to participate in the clinical assessments, follow-up protocol, and research-focused testing to identify gene mutations and potential treatment pathways.

This work has already contributed to important discoveries, including the identification of somatic mutations (e.g., MAP2K1, SMAD3) that help explain disease development and may inform future treatments or therapies.